Talanta, Journal Year: 2023, Volume and Issue: 266, P. 124963 - 124963
Published: July 17, 2023
Language: Английский
Journal of Multidisciplinary Healthcare, Journal Year: 2022, Volume and Issue: Volume 15, P. 21 - 45
Published: Jan. 1, 2022
Abstract: The delay or refusal of vaccination, which defines vaccine hesitancy, is a major challenge to successful control COVID-19 epidemic. huge number publications addressing hesitancy necessitates periodic review provide concise summary acceptance rates worldwide. In the current narrative review, data on were retrieved from surveys in 114 countries/territories. East and Southern Africa (n = 9), highest rate was reported Ethiopia (92%), while lowest Zimbabwe (50%). West/Central 13), Niger (93%), Cameroon (15%). Asia Pacific 16), Nepal Vietnam (97%), Hong Kong (42%). Eastern Europe/Central 7), Montenegro (69%) Kazakhstan (64%), Russia (30%). Latin America Caribbean 20), Mexico (88%), Haiti (43%). Middle East/North (MENA, n 22), Tunisia Iraq (13%). Western/Central Europe North 27), Canada (91%) Norway (89%), Cyprus Portugal (35%). ≥ 60% seen 72/114 countries/territories, compared 42 countries/territories with between 13% 59%. phenomenon appeared more pronounced MENA, Central Asia, Africa. More studies are recommended Africa, address intentions general public get vaccination. Keywords: SARS-CoV-2, hesitance, resistance, rejection, willingness vaccinate, intention vaccinate
Language: Английский
Citations
209
JMIR Public Health and Surveillance, Journal Year: 2021, Volume and Issue: 8(1), P. e29872 - e29872
Published: Oct. 20, 2021
Individuals with comorbid conditions have been disproportionately affected by COVID-19. Since regulatory trials of COVID-19 vaccines excluded those immunocompromising conditions, few patients cancer and autoimmune diseases were enrolled. With limited vaccine safety data available, vulnerable populations may conflicted attitudes.We assessed the prevalence independent predictors hesitancy acceptance among individuals serious comorbidities self-reported side effects who had vaccinated.We conducted a cross-sectional, 55-item, online survey, fielded January 15, 2021 through February 22, 2021, random sample members Inspire, an health community over 2.2 million conditions. Multivariable regression analysis was utilized to determine factors independently associated acceptance.Of 996,500 Inspire invited participate, responses received from 21,943 (2.2%). Respondents resided in 123 countries (United States: 16,277/21,943, 74.2%), median age range 56-65 years, highly educated (college or postgraduate degree: 10,198/17,298, 58.9%), diverse political leanings. All respondents at least one comorbidity: cancer, 27.3% (5459/19,980); diseases, 23.2% (4946/21,294); chronic lung diseases: 35.4% (7544/21,294). identified 18.6% (3960/21,294), 10.3% (2190/21,294) declaring that they would not, 3.5% (742/21,294) stating probably 4.8% (1028/21,294) not sure whether agree be vaccinated. Hesitancy expressed following patients: 13.4% (731/5459); 19.4% (962/4947); 17.8% (1344/7544). Positive included routine influenza vaccination (odds ratio [OR] 1.53), trust responsible development (OR 14.04), residing United States 1.31), never smoked 1.06). increased history prior 0.86), conservative leaning 0.93), younger 0.83), lower education level 0.90). One-quarter (5501/21,294, 25.8%) injection, 6.5% (1390/21,294) completed 2-dose series. Following first 69.0% (3796/5501) local reactions, 40.0% (2200/5501) systemic which second injection 77.0% (1070/1390) 67.0% (931/1390), respectively.In this survey significant remained. Assumptions most automatically accept are erroneous thus call for care team initiate discussions focusing on impact individual's underlying condition. Early effect experiences already vaccinated, as our population, should reassuring might alleviate fears. Health care-related social media forums rapidly disseminate accurate information about play important role.
Language: Английский
Citations
145
PLoS ONE, Journal Year: 2023, Volume and Issue: 18(4), P. e0280439 - e0280439
Published: April 12, 2023
Healthcare workers (HCWs) and healthcare students display high levels of vaccine hesitancy with impact on provision, patient safety, health promotion. The factors related to have been reported in several systematic reviews. However, this evidence needs be synthesised, as interventions reduce vaccination population are needed.
Language: Английский
Citations
51
Narra J, Journal Year: 2021, Volume and Issue: 1(3)
Published: Dec. 1, 2021
Vaccine hesitancy, defined as the reluctance or rejection in receiving a vaccine despite its availability, represents major challenge to global health efforts aiming control ongoing COVID-19 pandemic. Understanding possible factors correlated with hesitancy using refined well-informed approach can be helpful address phenomenon. The current study aimed evaluate acceptance rates four hypothetical scenarios of varying levels efficacy and safety profiles ten Asian, African South American countries. These included: 95% 20% side effects (Vaccine A), 75% 5% B); C) 50% D). This used self-administered online survey that was distributed during February–May 2021. total number respondents 1337 countries residence follows: India (21.1%), Pakistan (12.9%), Sudan (11.2%), Nigeria (9.3%), Iran (8.2%), Bangladesh Brazil (7.9%), Chile (7.7%), Tunisia (7.6%), Egypt (6.2%). overall for vaccination were variable based on degrees 55.6% C, 58.3% D, 74.0% A 80.1% B. highest observed followed by across different scenarios. lowest reported low (20% effects), scenario (50% efficacy). revealed potential effect intention get vaccination. At same level, higher possibility caused large drop rate. indicates importance accurate communication regarding attitude towards intentions vaccinated. Regional differences Middle East/North showing displaying rates.
Language: Английский
Citations
80
Vaccine, Journal Year: 2022, Volume and Issue: 40(12), P. 1888 - 1895
Published: Jan. 26, 2022
Language: Английский
Citations
49
Expert Review of Vaccines, Journal Year: 2022, Volume and Issue: 21(9), P. 1289 - 1300
Published: June 27, 2022
As for other vaccines, vaccination hesitancy may be a determining factor in the success (or otherwise) of COVID-19 immunization campaign healthcare workers (HCWs).To estimate proportion HCWs Italy who expressed vaccine hesitancy, we conducted systematic review relevant literature and meta-analysis. Determinants compliance options suggested by these studies to address among were also analyzed. Seventeen included meta-analysis review, selected from scientific articles available MEDLINE/PubMed, Google Scholar Scopus databases between 1 January 2020 25 2022. The rate was 13.1% (95%CI: 6.9-20.9%). investigated before during 18.2% (95%CI = 12.8-24.2%) 8.9% 3.4-16.6%), respectively. That main reasons hesitation lack information about vaccination, opinion that is unsafe, fear adverse events.Despite strategies achieve greater willingness immunize this category, mandatory appears one most important measures can guarantee protection patients they care for.
Language: Английский
Citations
44
Social Science & Medicine, Journal Year: 2022, Volume and Issue: 306, P. 115112 - 115112
Published: June 6, 2022
Language: Английский
Citations
39
JMIR Public Health and Surveillance, Journal Year: 2021, Volume and Issue: 7(12), P. e30424 - e30424
Published: Nov. 11, 2021
There are concerns that vaccine hesitancy may impede COVID-19 rollout and prevent the achievement of herd immunity. Vaccine is a delay in acceptance or refusal vaccines despite their availability.We aimed to identify which people more less likely take factors associated with inform public health messaging.A Canadian cross-sectional survey was conducted Canada October November 2020, prior regulatory approval vaccines. measured by respondents answering question "what would you do if were available you?" Negative binomial regression used hesitancy. Cluster analysis performed distinct clusters based on intention vaccine, beliefs about vaccines, adherence nonpharmaceutical interventions.Of 4498 participants, 2876 (63.9%) reported significantly (1) younger age (18-39 years), (2) lower education, (3) non-Liberal political leaning. Participants believe end pandemic benefits outweighed risks. Individuals had higher prevalence being concerned side effects, influenced peers care professionals, trust government institutions.These findings can be targeted messaging combat as administration continues. Messaging related preventing COVID among friends family, highlighting benefits, emphasizing safety efficacy vaccination, ensuring workers knowledgeable supported vaccination counselling effective for vaccine-hesitant populations.
Language: Английский
Citations
51
Vaccine, Journal Year: 2022, Volume and Issue: 41(2), P. 354 - 364
Published: Nov. 10, 2022
Multiple COVID-19 vaccines have now been licensed for human use, with other candidate in different stages of development. Effective and safe against essential achieving global reductions severe disease caused by acute respiratory coronavirus 2 (SARS-CoV-2), but multiple factors, including vaccine supply confidence, continue to impact uptake vaccines. In this study, we explore determinants vaccination intent across17 countries worldwide. large-scale multi-country explored accept a the socio-demographic emotional 17 over 19,000 individuals surveyed June July 2020 via nationally representative samples. We used Bayesian ordinal logistic regressions probe relationship between individuals' status, their confidence vaccines, recent status. Gibbs sampling was model inference, 95% highest posterior density intervals capture uncertainty. Intent found be India, where 77⋅8% (95% HPD, 75⋅5 80⋅0%) respondents strongly agreeing that they would take new if it were available. The Democratic Republic Congo (15⋅5%, 12⋅2 18⋅6%) France (26⋅4%, 23⋅7 29⋅2%) had lowest share who agreed COVID-19. Confidence safety, importance, effectiveness are most widely informative intent. Socio-demographic played lesser role, being male having higher education associated increased five fearful catching also strong determinant Barriers acceptance country context dependent. These findings highlight importance regular monitoring identify groups less likely vaccinate.
Language: Английский
Citations
36
Vaccines, Journal Year: 2022, Volume and Issue: 10(5), P. 806 - 806
Published: May 19, 2022
Healthcare students are clinicians-in-training likely to come into contact with COVID-19 as much other frontline healthcare professionals. It is therefore necessary prioritize vaccinations for this group. We conducted a global systematic assessment of vaccine acceptance rates and related factors among using the PubMed, Scopus, Web Science databases keyword searches in March 2022. found 1779 articles relevant information 31 that matched our inclusion criteria. performed random-effects meta-analysis quality eight-item Joanna Briggs Institute Critical Appraisal test cross-sectional studies. A total 30,272 individuals from 16 countries were studied. Most studies carried out U.S. (n = 6), China 5), Poland India 2), Italy Israel 2). The prevalence rate was 68.8% (95% confidence interval [CI]: 60.8–76.3, I2 100%), hesitancy 25.8% CI: 18.5–33.8, 99%). In country-specific analyses, Romania showed highest (88.0%, 95% 44.5–100%), while Iraq lowest (66.2%, 35.5–90.8%). time-trend we decreased over time. Students concerned about potentially serious side effects less willing accept vaccine. National international interventions should be adopted reduce vaccination these important workers.
Language: Английский
Citations
31